Results 211 to 220 of about 3,775 (250)

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Chemistry, Pharmacology, and Clinical Efficacy of the Chinese Nootropic Agent Huperzine A

Accounts of Chemical Research, 1999
Alan P. Kozikowski, Werner Tückmantel
openaire   +1 more source

P.8.a.029 The influence of the individual features of the patients on the efficacy of some nootropic agents in chronic alcoholism therapy

, 2008
Maxim L. Lovat, М.А. Винникова, A.V. Kozyreva, Ekaterina A. Kushnir, E.V. Efimova, A.A. Groznaya   +5 more
openalex   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Molecular determinants for drug-receptor interactionsPart 2. An ab initio molecular orbital and dipole moment study of the novel nootropic agent piracetam (2-oxopyrrolidin-1-ylacetamide)

, 1982
H. Lumbroso, Ch. Liégeois, Giuseppe Pappalardo, A. Grassi   +3 more
openalex   +1 more source